Pulmonary Disease in a Psychiatric Inpatient Population

NCT01823627 | Completed

• 1 other identifier: SJ-322
• Study Type: interventional
• Target: 46
• Locations: 1 country
• Sites: 1

Brief Summary

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking. Hypothesis Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history Method: 80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Conditions

Chronic Obstructive Airway Disease

Keywords

COPD; Psychiatric inpatient; Smoking

Outcome Measures

Primary Outcomes (1)

• Tiffeneau index

  \- FEV1/FVC ratio

  at enrollment

Secondary Outcomes (2)

• forced vital capacity

  at enrollment

• Forced expiratory volume in 1 second

  at enrollment

Study Arms (1)

Spirometry with reversibility test

OTHER

Spirometry with reversibility test

Procedure: Spirometry with reversibility test

Interventions

Spirometry with reversibility test PROCEDURE

Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration

Also known as: MicroLoop handheld transportable spirometer

Spirometry with reversibility test

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Inpatients in Psykiatrien Syd, Region Zealand, ward S1,S2,S3,S4,S5,S6
• Admission time over 48 hours

You may not qualify if:

• Patients who is not able to perform spirometry due to their psychiatric condition

Sponsors & Collaborators

• Psykiatrien Syd: lead
• Naestved Hospital: collaborator

Study Sites (1)

Psyciatrien Syd, Region Zealand

Vordingborg, 4760, Denmark

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Smoking

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Behavior

Study Officials

• Nicolai Renstrom

  Psykiatrien Syd

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: 1.Reservelæge

Study Record Dates

• First Submitted: March 26, 2013
• First Posted: April 4, 2013
• Study Start: March 1, 2013
• Primary Completion: June 1, 2013
• Study Completion: July 1, 2013
• Last Updated: May 24, 2018

Record last verified: 2018-05

Data Sharing

• IPD Sharing: Will not share

Locations

DK (1)